Pay in 4 interest-free payments of $6.07 Learn more
Ships within 48 hours · Estimated delivery Sep 2 - Sep 7
In a lab environment, BPC-157 has been studied for its potential in a variety of areas: Support the integrity of the gastrointestinal mucosa Enhance wound healing in skin, tendons, ligaments, and muscles Modulate inflammatory pathways and oxidative stress Interact with the brain-gut axis, a network that connects the nervous system and digestive system As a side note, though no less important, BPC-157 is considered an unapproved new drug and isnt FDA-approved for any human treatment
BPC-157, derived from a gastric protein, has been studied in preclinical models for its ability to promote angiogenesis and modulate growth factors
In another experiment, mice with cAtg3-KO-induced cardiac dysfunction were treated with 5-amino-1-MQ
Both compounds are administered subcutaneously, typically in the abdomen, thigh, or upper arm
Mechanism involves NO system modulation (homeostatic regulationupregulating when deficient, moderating when excessive), VEGF/VEGFR2 upregulation for angiogenesis, FAK-paxillin pathway activation for cell migration (40% increase per Chang et al.), and EGR-1 transcription factor upregulation for growth factor sensitivity
CagriSema: 13.7% body-weight reduction and 1.91 percentage-point HbA1c reduction vs placebo
US$ 29.32
US$ 27.64
US$ 23.76
US$ 25.57
US$ 28.67
US$ 25.07
US$ 28.01
